Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Wai Ke Za Zhi ; 60(8): 736-741, 2022 Jun 28.
Article in Chinese | MEDLINE | ID: mdl-35790525

ABSTRACT

The anastomotic vessels between the superior mesenteric artery and the inferior mesenteric artery are vital to maintain the blood supply of the anastomosis and residual colon after colectomy. However, current studies of anastomotic vessels are facing four major obstacles: confusing nomenclature, large variability in data, diversification of research methods and incomplete information records. The existence of marginal artery has been widely proved, and its significance for blood supply is well recognized by relevant studies. In contrast, the Riolan's arch, whose connotations constantly changed over history, can not refer to a specific structure accurately. Researchers should abolish the controversial names such as Riolan's arch, select appropriate research methods and record the anastomotic vessels in detail, so as to improve the comparability between different results. The study of anastomotic vessels can help us to identify potential vascular disease, select the appropriate surgical approach, and provide appropriate treatment of the vessels in the operating area, so as to provide a theoretical foundation and practical basis for fine surgical maneuvers.

2.
Zhonghua Er Ke Za Zhi ; 60(3): 197-202, 2022 Mar 02.
Article in Chinese | MEDLINE | ID: mdl-35240738

ABSTRACT

Objective: To investigate the prognostic factors of children with congenital heart disease (CHD) who had undergone cardiopulmonary resuscitation (CPR) in pediatric intensive care unit (PICU) in China. Methods: From November 2017 to October 2018, this retrospective multi-center study was conducted in 11 hospitals in China. It contained data from 281 cases who had undergone CPR and all of the subjects were divided into CHD group and non-CHD group. The general condition, duration of CPR, epinephrine doses during resuscitation, recovery of spontaneous circulation (ROSC), discharge survival rate and pediatric cerebral performance category in viable children at discharge were compared. According to whether malignant arrhythmia is the direct cause of cardiopulmonary arrest or not, children in CHD and non-CHD groups were divided into 2 subgroups: arrhythmia and non-arrhythmia, and the ROSC and survival rate to discharge were compared. Data in both groups were analyzed by t-test, chi-square analysis or ANOVA, and logistic regression were used to analyze the prognostic factors for ROSC and survival to discharge after cardiac arrest (CA). Results: The incidence of CA in PICU was 3.2% (372/11 588), and the implementation rate of CPR was 75.5% (281/372). There were 144 males and 137 females with median age of 32.8 (5.6, 42.7) months in all 281 CPA cases who received CPR. CHD group had 56 cases while non-CHD had 225 cases, with the percentage of 19.9% (56/281) and 80.1% (225/281) respectively. The proportion of female in CHD group was 60.7% (34/56) which was higher than that in non-CHD group (45.8%, 103/225) (χ2=4.00, P=0.045). There were no differences in ROSC and rate of survival to discharge between the two groups (P>0.05). The ROSC rate of children with arthythmid in CHD group was 70.0% (28/40), higher than 6/16 for non-arrhythmic children (χ2=5.06, P=0.024). At discharge, the pediatric cerebral performance category scores (1-3 scores) of CHD and non-CHD child were 50.9% (26/51) and 44.9% (92/205) respectively. Logistic regression analysis indicated that the independent prognostic factors of ROSC and survival to discharge in children with CHD were CPR duration (odds ratio (OR)=0.95, 0.97; 95%CI: 0.92~0.97, 0.95~0.99; both P<0.05) and epinephrine dosage (OR=0.87 and 0.79, 95%CI: 0.76-1.00 and 0.69-0.89, respectively; both P<0.05). Conclusions: There is no difference between CHD and non-CHD children in ROSC and survival rate of survival to discharge was low. The epinephrine dosage and the duration of CPR are related to the ROSC and survival to discharge of children with CHD.


Subject(s)
Cardiopulmonary Resuscitation , Heart Arrest , Heart Defects, Congenital , Child , Child, Preschool , Female , Heart Arrest/therapy , Heart Defects, Congenital/therapy , Humans , Intensive Care Units, Pediatric , Male , Retrospective Studies
3.
Zhonghua Wei Chang Wai Ke Za Zhi ; 24(10): 925-930, 2021 Oct 25.
Article in Chinese | MEDLINE | ID: mdl-34674469

ABSTRACT

Sexual dysfunction with the incidence of 5%-90% is a common postoperative complication of rectal cancer and the ratio of men and women is similar. Sexual function is innervated by the abdominal-pelvic autonomic nerve. Different sexual dysfunctions can be caused by different parts and degrees of injury in autonomic nerve during operations of rectal cancer. With the development of pelvic autonomic nerves preservation in rectal cancer radical resection, postoperative sexual function can be protected. There may be many factors increasing the incidence of postoperative sexual dysfunction in rectal cancer, such as postoperative psychological factors, stoma, abdominal-perineal resection and radiotherapy. The effects of laparoscopic surgery, robotic surgery, transanal total mesorectal excision and lateral lymph node dissection on postoperative sexual function remain controversial. Based on the multidisciplinary cooperation model, attention should be paid to psychological intervention of patients and their partners. In clinical practice, for male using phosphodiesterase-5 inhibitors, vacuum erectile devices, injection of vasodilators through the penis or urethra, and for female local application of estrogen and lubricants in the vagina are effective treatment for postoperative sexual dysfunction of rectal cancer. In addition, stem cell therapy has a promising prospect for sexual dysfunction.


Subject(s)
Laparoscopy , Rectal Neoplasms , Sexual Dysfunction, Physiological , Female , Humans , Lymph Node Excision , Male , Rectal Neoplasms/surgery , Rectum/surgery , Sexual Dysfunction, Physiological/etiology
4.
Eur Rev Med Pharmacol Sci ; 25(7): 2885-2897, 2021 04.
Article in English | MEDLINE | ID: mdl-33877653

ABSTRACT

Triple-negative breast cancer (TNBC) accounts for approximately 15-20% of all breast cancers, and its poor response to treatment has been a major problem in the field of breast cancer. In recent years, the application of immune checkpoint inhibitors has introduced a new era of treatment. The IMpassion 130 trial used PD-L1 as a mature biomarker for immunotherapy in metastatic TNBC, but the population screened, which was only patients with positive PD-L1 expression, was too narrow. Otherwise, it could not be determined whether the PD-L1-positive group benefited from immunotherapy in early TNBC, but this was confirmed in the KEYNOTE-522 and IMpassion 031 studies, in which there was no significant difference in the benefit, whether patients were PD-L1-positive or not. Therefore, how to screen more suitable biomarkers for accurate immunotherapy has become a burning and persistent problem to be solved. In fact, immune infiltration has always been our focus in the process of exploring immunotherapy in TNBC, and tumor infiltrating lymphocytes (TILs) have been well-known for decades as a prognostic factor in early TNBC. Furthermore, TILs are positively correlated with both patient survival and pathological complete response (pCR) after neoadjuvant chemotherapy. Recently, increasingly more foundational experiments and clinical trial verifications suggest that TILs could contain more biomarkers. Thus, in this review, we will assess the composition and heterogeneity of TILs, their evaluation standards, their relationship with TNBC prognosis and the prediction ability of different treatment options in TNBC, and their correlation with other biomarkers in the clinical application. We also summarize new studies that show the future potential of TILs.


Subject(s)
Biomarkers, Tumor/analysis , Lymphocytes, Tumor-Infiltrating/chemistry , Triple Negative Breast Neoplasms/diagnosis , Female , Humans , Prognosis , Tumor Microenvironment
5.
Eur Rev Med Pharmacol Sci ; 24(24): 13065-13071, 2020 12.
Article in English | MEDLINE | ID: mdl-33378060

ABSTRACT

OBJECTIVE: Whether patients with COVID-19 require invasive mechanical ventilation (MV) is not yet clear. This article summarizes the clinical treatment process and clinical data of patients with COVID-19 and analyzes the predictive factors for mechanical ventilation for these patients. MATERIALS AND METHODS: A retrospective study was carried out from January 5, 2020, to March 23, 2020, including 98 patients with COVID-19 treated at three designated hospitals in Huangshi City, Hubei Province. Data collection included demographics, previous underlying diseases, clinical manifestations, laboratory examinations, imaging examination results, diagnosis, and prognosis. This study presents a summary of the patients' overall clinical characteristics and clarifies the predictive factors for MV in patients with COVID-19. RESULTS: There were 56 males and 42 females included in this study. The mortality rate was 26.53% (26/98). Fever, cough, and chest tightness were the most common symptoms (64.3%, 37.8%, and 12.2%, respectively). Thirty cases required MV, 30.61% of the total cases, and the mortality rate was 73.33%. The univariate comparison showed that dyspnea, acute physiologic assessment, chronic health evaluation (APACHE II) score, and the ratio between arterial blood oxygen partial pressure (PaO2) and oxygen concentration (FiO2) (P/F) were statistically different between the MV group and the non-MV group (p < 0.05). CONCLUSIONS: Results showed the following: dyspnea; increased white blood cell count; decreased platelets; lowered albumin levels; increased urea nitrogen; increased levels of myocardial enzymes Creatine Kinase (CK), Creatine Kinase, MB Form (CKMB) and lactate dehydrogenase (LDH); increased lactate, and lowered blood calcium tests. These findings may indicate that the patients have an increased probability of needing MV support. A cutoff value for the initial APACHE II score of >11.5 and the initial PaO2/FiO2 ratio of <122.17 mmHg should be considered for MV support for patients with COVID-19.


Subject(s)
COVID-19/therapy , Oxygen/blood , Partial Pressure , Respiration, Artificial/statistics & numerical data , APACHE , Aged , Aged, 80 and over , Area Under Curve , Blood Urea Nitrogen , COVID-19/blood , COVID-19/mortality , COVID-19/physiopathology , Creatine Kinase/blood , Creatine Kinase, MB Form/blood , Dyspnea/physiopathology , Female , Humans , Hypoalbuminemia/blood , Hypocalcemia/blood , L-Lactate Dehydrogenase/blood , Lactic Acid/blood , Leukocytosis/blood , Male , Middle Aged , ROC Curve , Retrospective Studies , Risk Assessment , SARS-CoV-2 , Thrombocytopenia/blood
6.
Zhonghua Wai Ke Za Zhi ; 58(8): 619-625, 2020 Aug 01.
Article in Chinese | MEDLINE | ID: mdl-32727194

ABSTRACT

Objective: To compare the postoperative functional prognosis of transanal mesorectal excision (taTME) and conventional total mesorectal excision (TME) in rectal cancer. Methods: Totally 49 patients underwent taTME and 478 patients underwent conventional TME at Department of Gastroenterological Surgery, Peking University People's Hospital from January 2015 to December 2019 were retrospectively collected. Propensity score matching method was used to perform 1 versus 1 matching between the taTME and conventional TME groups, and 36 pairs of patients were successfully matched. After matching, the median age of patients in taTME group and conventional TME group was 60.5 (16.0) years and 60.5 (13.0) years (M(Q(R))), respectively, and the proportion of male patients was 66.7% (24/36) and 55.6% (20/36) , respectively. EORTC QLQ-C30 scale was used to assess quality of life, low anterior resection syndrome (LARS) scale and Wexner constipation score were used to evaluate anal function, international prostate symptom score (IPSS) was used to evaluate urinary function,international index of erectile function (IIEF) -5 and female sexual function index (FSFI) score were used to evaluate male and female sexual function, respectively, and generalized anxiety disorder (GAD-7) and patient health questionnaire (PHQ-9) scale were used to evaluate psych function. The t test, Mann-Whitney U test, χ(2) test, and Fisher exact test were used for comparison between groups, and Wilcoxon rank sum test or McNemar test was used for comparison between paired data. Results: There were no significant differences in surgery time, postoperative hospital stays, conversion rate, morbidity rate, surgery cost, and numbers of lymph node yield between the two groups (all P>0.05). Compared with the conventional TME group, the intraoperative blood loss in the taTME group was significantly higher (100 (100) ml vs. 80 (50) ml, U=424.5, P=0.010), the prophylactic stoma rate was significantly higher (96.9%(31/36) vs. 63.6%(21/36), χ(2)=11.218, P<0.01), the total hospitalization cost was significantly lower (74 297.7 (16 746.4) CNY vs. 91 781.3 (26 228.4) CNY, U=413.0, P=0.008). There were no significant differences in anal and urinary function between the two groups (LARS scalescore: Z=-0.513, P=0.608, Wexner constipation score: Z=-0.992, P=0.321, IPSS: Z=-1.807, P=0.071). In terms of psych function, significant difference in GAD-7 scale was seen between the two groups (Z=-2.311, P=0.021), patients with generalized anxiety disorder accounting for 26.7% (8/30) and 46.9% (15/32), respectively. Conclusions: Compared with conventional TME surgery, taTME has a significantly increased blood loss and prophylactic stoma rate. There are no significant difference in the incidence of postoperative anal, urinary, and sexual dysfunction between taTME and conventinal TME. taTME can alleviate the financial burden and general anxiety disorder to a certain extent.


Subject(s)
Proctectomy/adverse effects , Rectal Neoplasms/surgery , Rectum/surgery , Transanal Endoscopic Surgery/adverse effects , Aged , Female , Humans , Laparoscopy , Male , Mesentery/surgery , Middle Aged , Proctectomy/methods , Prognosis , Propensity Score , Quality of Life , Retrospective Studies , Treatment Outcome
7.
Neuroscience ; 160(2): 319-29, 2009 May 05.
Article in English | MEDLINE | ID: mdl-19272418

ABSTRACT

Local microenvironment plays an important role in determining the fate choice of stem cells in the central nervous system (CNS). Astrocytes, a major component of local microenvironment in the CNS, have been demonstrated to influence the proliferation and neural differentiation of stem cells including neural stem/progenitor cells, embryonic stem cells and bone marrow stromal cells (BMSCs). However, it has remained to be ascertained if inflammation-activated astrocytes can affect the behavior of BMSCs. To this end, astrocyte-conditioned medium (ACM) was prepared in this study for treatment of BMSCs. The ACM derived from Wistar rat astrocytes stimulated by lipopolysaccharide for 12, 36 or 72 h, respectively, served as inflammatory ACM (12 h ACM, 36 h ACM and 72 h ACM), while that from unstimulated astrocytes was used as normal control astrocyte-conditioned medium (N-ACM). The results showed that the proliferation and neural differentiation of BMSCs grown in inflammatory ACM were significantly increased compared with those grown in N-ACM. The efficiency of BMSCs exposed to 36 h ACM was significantly greater than that of those exposed to 12 or 72 h ACM. Following neutralization of interleukin-6 (IL-6) of the ACM, both the proliferation and astrocytic differentiation of BMSCs were decreased; on the other hand, the neuronal differentiation was significantly increased. The present findings suggest that inflammation-activated astrocytes can facilitate the proliferation and neural differentiation of BMSCs and activated astrocytes at different phase after CNS injuries might have distinct effects on BMSCs. Moreover, astrocyte-derived IL-6 participates in the proliferation and neural differentiation of BMSCs.


Subject(s)
Astrocytes/physiology , Bone Marrow Cells/cytology , Cell Differentiation/physiology , Neurogenesis/physiology , Stem Cells/cytology , Animals , Astrocytes/cytology , Biological Factors/physiology , Bone Marrow Cells/physiology , Cell Proliferation , Coculture Techniques , Culture Media, Conditioned , Interleukin-6/physiology , Rats , Rats, Wistar , Stem Cells/physiology , Stromal Cells
8.
Zhonghua Wai Ke Za Zhi ; 32(4): 246-8, 1994 Apr.
Article in Chinese | MEDLINE | ID: mdl-7531136

ABSTRACT

66 cases of prostatic hypertrophy have been treated by transurethral non-contact Nd:YAG laser irradiation since April 1993. Sixty patients regained unobstructed urination within 1 week and 6 within 2 weeks after operation. The symptoms of the treated group were improved with the necrotic tissues gradually peeling off in 3 to 6 weeks. The short-term follow-up indicated that the prostatic gland distinctly reduced and residual urine decreased or vanished after treatment. Three patients had one of the following complications: urinary tract infection, epididymitis or urinous infiltration. These complications were treated appropriately. This therapy is ideal for the treatment of prostatic hypertrophy.


Subject(s)
Laser Therapy , Prostatectomy/methods , Prostatic Hyperplasia/surgery , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged
9.
Lasers Surg Med ; 4(1): 31-7, 1984.
Article in English | MEDLINE | ID: mdl-6235413

ABSTRACT

This paper reports results of hematoporphyrin derivative based on photodynamic therapy (PDT) of 24 lung cancer lesions in 21 patients that were followed at least three months. Three of 24 lesions exhibited complete remission and 20 of 24 lesions exhibited a response to PDT. Tumors in twenty of twenty-one patients exhibited visually discernible hematoporphyrin derivative fluorescence upon irradiation with the 514-nm line from an argon ion laser. There were no severe complications due to PDT. The hematoporphyrin derivative, argon iin laser pumped dye laser (rhodamine B) system,and quartz fiber we used in this clinical series were all made in the People's Republic of China.


Subject(s)
Adenocarcinoma/drug therapy , Carcinoma, Squamous Cell/drug therapy , Hematoporphyrins/therapeutic use , Laser Therapy , Lung Neoplasms/drug therapy , Photochemotherapy , Radiation-Sensitizing Agents/therapeutic use , Adult , Follow-Up Studies , Hematoporphyrin Derivative , Humans , Male , Middle Aged , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...